Advertisement
Document › Details
Evotec AG. (2/7/19). "Press Release: Evotec Mourns Loss of Company Co-founder Prof. Manfred Eigen". Hamburg.
Evotec AG mourns the loss of Nobel laureate and Company co-founder Prof. Manfred Eigen, who passed away Wednesday at the age of 91.
Prof. Eigen was born in Bochum in 1927 into a family of musicians. When the Second World War crossed his original plans to study music as well, Manfred Eigen decided to study the “harmonies” of molecules, instead. In 1967, the biophysical chemist received the Nobel Prize in Chemistry. He founded the Max Planck Institute for Biophysical Chemistry (MPI-BPC) in Goettingen, and was among the co-founders of Evotec in 1993.
Evotec’s board and the workforce will remember Prof. Eigen as a true innovator whose vision of evolutionary biotechnology laid the foundation of modern-day drug discovery. Prof. Eigen always maintained close connections with Evotec, and was a guest of honour when the Company opened its research site in Hamburg in 2012. The site, which was named “Manfred Eigen Campus” in his honour remains Evotec’s headquarters to this day.
Dr Werner Lanthaler, Chief Executive Officer of Evotec, said: “It is with great sadness, that we have received the news about the passing of our company’s co-founder Prof. Manfred Eigen, one of the great geniuses of our time. It is simply impossible to overstress the profound influence that Manfred Eigen’s work has had on modern drug discovery. Our thoughts are with his wife, Dr. Ruthild Oswatitsch-Eigen, and his family.”
Record changed: 2023-06-05 |
Advertisement
More documents for Evotec (Group)
- [1] Evotec SE. (1/4/24). "Press Release: Evotec and Owkin Enter an A.I.-powered Strategic Partnership to Accelerate Therapeutics Pipeline in Oncology and I&I". Hamburg & Paris....
- [2] Evotec SE. (1/3/24). "Press Release: Evotec Announces CEO Transition. Dr. Werner Lanthaler to Step Down as CEO". Hamburg....
- [3] Evotec SE. (10/5/23). "Press Release: Evotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners Launch '65LAB'". Hamburg & Singapore....
- [4] Evotec SE. (7/11/23). "Press Release: Evotec and Bristol Myers Squibb Enter Licence Agreement within Neuroscience Partnership". Hamburg....
- [5] Evotec SE. (5/12/23). "Press Release: Evotec Publishes Annual Report 2022 and Quarterly Statement for Q1 2023". Hamburg....
- [6] Evotec SE. (5/9/23). "Press Release: Just – Evotec Biologics Launches Tech Partnership for Biosimilars Development and Commercial Manufacturing". Hamburg & Seattle, WA....
- [7] Evotec SE. (2/10/23). "Press Release: Evotec Receives € 150 m Loan from European Investment Bank". Hamburg & Toulouse....
- [8] Evotec SE. (2/7/23). "Press Release: Laetitia Rouxel to Succeed Enno Spillner as Chief Financial Officer". Hamburg....
- [9] Formycon AG. (2/7/23). "Press Release: Enno Spillner Appointed Chief Financial Officer (CFO) of Formycon AG". Munich....
- [10] Evotec SE. (1/26/23). "Press Release: Evotec Announces Agreement with Janssen to Develop Immune-based Therapies". Hamburg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top